nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminophylline—HDAC2—hematologic cancer	0.342	1	CbGaD
Aminophylline—HDAC2—Vorinostat—hematologic cancer	0.138	0.327	CbGbCtD
Aminophylline—PDE3A—Anagrelide—hematologic cancer	0.126	0.299	CbGbCtD
Aminophylline—CYP1A2—Anagrelide—hematologic cancer	0.0142	0.0337	CbGbCtD
Aminophylline—CYP2E1—Thalidomide—hematologic cancer	0.00906	0.0216	CbGbCtD
Aminophylline—CYP2E1—Dacarbazine—hematologic cancer	0.0078	0.0185	CbGbCtD
Aminophylline—CYP1A2—Carmustine—hematologic cancer	0.00744	0.0177	CbGbCtD
Aminophylline—CYP1A2—Methoxsalen—hematologic cancer	0.00633	0.015	CbGbCtD
Aminophylline—CYP2E1—Mitoxantrone—hematologic cancer	0.00605	0.0144	CbGbCtD
Aminophylline—CYP1A2—Bortezomib—hematologic cancer	0.00602	0.0143	CbGbCtD
Aminophylline—CYP1A2—Daunorubicin—hematologic cancer	0.00576	0.0137	CbGbCtD
Aminophylline—CYP1A2—Alitretinoin—hematologic cancer	0.00564	0.0134	CbGbCtD
Aminophylline—CYP1A2—Thalidomide—hematologic cancer	0.00524	0.0125	CbGbCtD
Aminophylline—CYP3A4—Bexarotene—hematologic cancer	0.00514	0.0122	CbGbCtD
Aminophylline—CYP3A4—Lomustine—hematologic cancer	0.00478	0.0114	CbGbCtD
Aminophylline—CYP3A4—Busulfan—hematologic cancer	0.00478	0.0114	CbGbCtD
Aminophylline—CYP1A2—Dacarbazine—hematologic cancer	0.00451	0.0107	CbGbCtD
Aminophylline—CYP1A2—Imatinib—hematologic cancer	0.00441	0.0105	CbGbCtD
Aminophylline—CYP3A4—Thiotepa—hematologic cancer	0.00426	0.0101	CbGbCtD
Aminophylline—CYP2E1—Etoposide—hematologic cancer	0.00381	0.00907	CbGbCtD
Aminophylline—CYP1A2—Dasatinib—hematologic cancer	0.00354	0.00842	CbGbCtD
Aminophylline—CYP3A4—Methoxsalen—hematologic cancer	0.00331	0.00788	CbGbCtD
Aminophylline—CYP3A4—Bortezomib—hematologic cancer	0.00315	0.0075	CbGbCtD
Aminophylline—CYP2E1—Dexamethasone—hematologic cancer	0.00314	0.00746	CbGbCtD
Aminophylline—CYP3A4—Daunorubicin—hematologic cancer	0.00302	0.00717	CbGbCtD
Aminophylline—CYP3A4—Cytarabine—hematologic cancer	0.00266	0.00632	CbGbCtD
Aminophylline—CYP3A4—Teniposide—hematologic cancer	0.00262	0.00623	CbGbCtD
Aminophylline—CYP3A4—Ifosfamide—hematologic cancer	0.00242	0.00575	CbGbCtD
Aminophylline—CYP3A4—Imatinib—hematologic cancer	0.00231	0.00549	CbGbCtD
Aminophylline—CYP1A2—Etoposide—hematologic cancer	0.00221	0.00524	CbGbCtD
Aminophylline—CYP3A4—Ruxolitinib—hematologic cancer	0.00218	0.00517	CbGbCtD
Aminophylline—CYP3A4—Nilotinib—hematologic cancer	0.0021	0.00499	CbGbCtD
Aminophylline—CYP3A4—Vinorelbine—hematologic cancer	0.00208	0.00495	CbGbCtD
Aminophylline—CYP3A4—Triamcinolone—hematologic cancer	0.0019	0.00453	CbGbCtD
Aminophylline—CYP3A4—Dasatinib—hematologic cancer	0.00186	0.00441	CbGbCtD
Aminophylline—CYP3A4—Mitoxantrone—hematologic cancer	0.00183	0.00436	CbGbCtD
Aminophylline—CYP3A4—Betamethasone—hematologic cancer	0.00163	0.00388	CbGbCtD
Aminophylline—CYP3A4—Prednisolone—hematologic cancer	0.00161	0.00383	CbGbCtD
Aminophylline—CYP3A4—Prednisone—hematologic cancer	0.00152	0.00362	CbGbCtD
Aminophylline—CYP3A4—Irinotecan—hematologic cancer	0.00144	0.00343	CbGbCtD
Aminophylline—ADORA2A—hematopoietic system—hematologic cancer	0.00144	0.0555	CbGeAlD
Aminophylline—Theophylline—HDAC2—hematologic cancer	0.00141	0.667	CrCbGaD
Aminophylline—CYP3A4—Vinblastine—hematologic cancer	0.00128	0.00305	CbGbCtD
Aminophylline—PDE3A—hematopoietic system—hematologic cancer	0.00128	0.0492	CbGeAlD
Aminophylline—CYP3A4—Vincristine—hematologic cancer	0.00126	0.003	CbGbCtD
Aminophylline—ADORA1—hematopoietic system—hematologic cancer	0.00124	0.0479	CbGeAlD
Aminophylline—HDAC2—hematopoietic system—hematologic cancer	0.00123	0.0473	CbGeAlD
Aminophylline—CYP3A4—Etoposide—hematologic cancer	0.00116	0.00275	CbGbCtD
Aminophylline—ADORA2B—blood—hematologic cancer	0.00115	0.0442	CbGeAlD
Aminophylline—ADORA2A—gonad—hematologic cancer	0.0011	0.0422	CbGeAlD
Aminophylline—ADORA2B—lung—hematologic cancer	0.00101	0.0387	CbGeAlD
Aminophylline—ADORA2A—blood—hematologic cancer	0.000955	0.0368	CbGeAlD
Aminophylline—CYP3A4—Dexamethasone—hematologic cancer	0.00095	0.00226	CbGbCtD
Aminophylline—ADORA2B—testis—hematologic cancer	0.000949	0.0366	CbGeAlD
Aminophylline—HDAC2—gonad—hematologic cancer	0.000934	0.036	CbGeAlD
Aminophylline—PDE4A—lung—hematologic cancer	0.000896	0.0345	CbGeAlD
Aminophylline—HDAC2—Topotecan—Irinotecan—hematologic cancer	0.000861	0.494	CbGdCrCtD
Aminophylline—PDE4A—testis—hematologic cancer	0.000846	0.0326	CbGeAlD
Aminophylline—PDE3A—blood—hematologic cancer	0.000846	0.0326	CbGeAlD
Aminophylline—HDAC2—blood—hematologic cancer	0.000814	0.0314	CbGeAlD
Aminophylline—ADORA2A—testis—hematologic cancer	0.00079	0.0304	CbGeAlD
Aminophylline—CYP3A4—Doxorubicin—hematologic cancer	0.000788	0.00187	CbGbCtD
Aminophylline—HDAC2—bone marrow—hematologic cancer	0.000788	0.0303	CbGeAlD
Aminophylline—PDE3A—lung—hematologic cancer	0.000741	0.0286	CbGeAlD
Aminophylline—ADORA1—lung—hematologic cancer	0.000723	0.0278	CbGeAlD
Aminophylline—HDAC2—lung—hematologic cancer	0.000714	0.0275	CbGeAlD
Aminophylline—Theophylline—PDE4B—hematologic cancer	0.000705	0.333	CrCbGaD
Aminophylline—PDE3A—testis—hematologic cancer	0.0007	0.027	CbGeAlD
Aminophylline—ADORA1—testis—hematologic cancer	0.000682	0.0263	CbGeAlD
Aminophylline—HDAC2—testis—hematologic cancer	0.000673	0.0259	CbGeAlD
Aminophylline—PDE4A—lymph node—hematologic cancer	0.000613	0.0236	CbGeAlD
Aminophylline—CYP1A2—hematopoietic system—hematologic cancer	0.000565	0.0218	CbGeAlD
Aminophylline—CYP2E1—hematopoietic system—hematologic cancer	0.000508	0.0196	CbGeAlD
Aminophylline—PDE3A—lymph node—hematologic cancer	0.000507	0.0195	CbGeAlD
Aminophylline—HDAC2—Menadione—Thalidomide—hematologic cancer	0.000494	0.284	CbGdCrCtD
Aminophylline—ADORA1—lymph node—hematologic cancer	0.000494	0.019	CbGeAlD
Aminophylline—HDAC2—lymph node—hematologic cancer	0.000488	0.0188	CbGeAlD
Aminophylline—CYP3A4—hematopoietic system—hematologic cancer	0.000409	0.0158	CbGeAlD
Aminophylline—HDAC2—Teniposide—Etoposide—hematologic cancer	0.000388	0.223	CbGdCrCtD
Aminophylline—CYP1A2—blood—hematologic cancer	0.000374	0.0144	CbGeAlD
Aminophylline—CYP2E1—blood—hematologic cancer	0.000337	0.013	CbGeAlD
Aminophylline—CYP1A2—lung—hematologic cancer	0.000328	0.0126	CbGeAlD
Aminophylline—CYP2E1—lung—hematologic cancer	0.000295	0.0114	CbGeAlD
Aminophylline—CYP2E1—testis—hematologic cancer	0.000279	0.0107	CbGeAlD
Aminophylline—CYP3A4—blood—hematologic cancer	0.000271	0.0104	CbGeAlD
Aminophylline—Body temperature increased—Cisplatin—hematologic cancer	3.06e-05	0.000232	CcSEcCtD
Aminophylline—Vomiting—Thalidomide—hematologic cancer	3.03e-05	0.000231	CcSEcCtD
Aminophylline—Anxiety—Dexamethasone—hematologic cancer	3.03e-05	0.00023	CcSEcCtD
Aminophylline—Anxiety—Betamethasone—hematologic cancer	3.03e-05	0.00023	CcSEcCtD
Aminophylline—Dizziness—Carmustine—hematologic cancer	3.03e-05	0.00023	CcSEcCtD
Aminophylline—Rash—Thalidomide—hematologic cancer	3.01e-05	0.000229	CcSEcCtD
Aminophylline—Dermatitis—Thalidomide—hematologic cancer	3e-05	0.000228	CcSEcCtD
Aminophylline—Dizziness—Alitretinoin—hematologic cancer	3e-05	0.000228	CcSEcCtD
Aminophylline—Diarrhoea—Vincristine—hematologic cancer	2.99e-05	0.000227	CcSEcCtD
Aminophylline—Headache—Thalidomide—hematologic cancer	2.99e-05	0.000227	CcSEcCtD
Aminophylline—Haematuria—Epirubicin—hematologic cancer	2.97e-05	0.000226	CcSEcCtD
Aminophylline—Dizziness—Ifosfamide—hematologic cancer	2.96e-05	0.000225	CcSEcCtD
Aminophylline—Pruritus—Gemcitabine—hematologic cancer	2.93e-05	0.000223	CcSEcCtD
Aminophylline—Nausea—Thiotepa—hematologic cancer	2.93e-05	0.000223	CcSEcCtD
Aminophylline—Anaphylactic shock—Dexamethasone—hematologic cancer	2.91e-05	0.000222	CcSEcCtD
Aminophylline—Anaphylactic shock—Betamethasone—hematologic cancer	2.91e-05	0.000222	CcSEcCtD
Aminophylline—Hyperglycaemia—Doxorubicin—hematologic cancer	2.91e-05	0.000222	CcSEcCtD
Aminophylline—Diarrhoea—Irinotecan—hematologic cancer	2.91e-05	0.000222	CcSEcCtD
Aminophylline—Diarrhoea—Mitoxantrone—hematologic cancer	2.91e-05	0.000222	CcSEcCtD
Aminophylline—Vomiting—Carmustine—hematologic cancer	2.91e-05	0.000221	CcSEcCtD
Aminophylline—Insomnia—Triamcinolone—hematologic cancer	2.9e-05	0.000221	CcSEcCtD
Aminophylline—Gastrointestinal pain—Etoposide—hematologic cancer	2.9e-05	0.00022	CcSEcCtD
Aminophylline—Infection—Dexamethasone—hematologic cancer	2.89e-05	0.00022	CcSEcCtD
Aminophylline—Infection—Betamethasone—hematologic cancer	2.89e-05	0.00022	CcSEcCtD
Aminophylline—Dizziness—Vincristine—hematologic cancer	2.89e-05	0.00022	CcSEcCtD
Aminophylline—Rash—Carmustine—hematologic cancer	2.89e-05	0.00022	CcSEcCtD
Aminophylline—Dermatitis—Carmustine—hematologic cancer	2.88e-05	0.000219	CcSEcCtD
Aminophylline—Vomiting—Alitretinoin—hematologic cancer	2.88e-05	0.000219	CcSEcCtD
Aminophylline—Headache—Carmustine—hematologic cancer	2.87e-05	0.000218	CcSEcCtD
Aminophylline—Shock—Betamethasone—hematologic cancer	2.87e-05	0.000218	CcSEcCtD
Aminophylline—Shock—Dexamethasone—hematologic cancer	2.87e-05	0.000218	CcSEcCtD
Aminophylline—Rash—Alitretinoin—hematologic cancer	2.86e-05	0.000218	CcSEcCtD
Aminophylline—Nervous system disorder—Dexamethasone—hematologic cancer	2.86e-05	0.000217	CcSEcCtD
Aminophylline—Nervous system disorder—Betamethasone—hematologic cancer	2.86e-05	0.000217	CcSEcCtD
Aminophylline—Agitation—Prednisone—hematologic cancer	2.86e-05	0.000217	CcSEcCtD
Aminophylline—Dermatitis—Alitretinoin—hematologic cancer	2.86e-05	0.000217	CcSEcCtD
Aminophylline—Vomiting—Ifosfamide—hematologic cancer	2.85e-05	0.000217	CcSEcCtD
Aminophylline—Hypersensitivity—Cisplatin—hematologic cancer	2.85e-05	0.000217	CcSEcCtD
Aminophylline—Tachycardia—Dexamethasone—hematologic cancer	2.84e-05	0.000216	CcSEcCtD
Aminophylline—Tachycardia—Betamethasone—hematologic cancer	2.84e-05	0.000216	CcSEcCtD
Aminophylline—Headache—Alitretinoin—hematologic cancer	2.84e-05	0.000216	CcSEcCtD
Aminophylline—Diarrhoea—Gemcitabine—hematologic cancer	2.84e-05	0.000216	CcSEcCtD
Aminophylline—Nausea—Thalidomide—hematologic cancer	2.83e-05	0.000215	CcSEcCtD
Aminophylline—Dyspepsia—Triamcinolone—hematologic cancer	2.83e-05	0.000215	CcSEcCtD
Aminophylline—Rash—Ifosfamide—hematologic cancer	2.83e-05	0.000215	CcSEcCtD
Aminophylline—Dermatitis—Ifosfamide—hematologic cancer	2.82e-05	0.000215	CcSEcCtD
Aminophylline—Dizziness—Irinotecan—hematologic cancer	2.81e-05	0.000214	CcSEcCtD
Aminophylline—Urticaria—Etoposide—hematologic cancer	2.81e-05	0.000214	CcSEcCtD
Aminophylline—Abdominal pain—Etoposide—hematologic cancer	2.8e-05	0.000213	CcSEcCtD
Aminophylline—Body temperature increased—Etoposide—hematologic cancer	2.8e-05	0.000213	CcSEcCtD
Aminophylline—Vomiting—Vincristine—hematologic cancer	2.78e-05	0.000211	CcSEcCtD
Aminophylline—Anorexia—Betamethasone—hematologic cancer	2.78e-05	0.000211	CcSEcCtD
Aminophylline—Anorexia—Dexamethasone—hematologic cancer	2.78e-05	0.000211	CcSEcCtD
Aminophylline—Urticaria—Prednisolone—hematologic cancer	2.77e-05	0.000211	CcSEcCtD
Aminophylline—Rash—Vincristine—hematologic cancer	2.76e-05	0.00021	CcSEcCtD
Aminophylline—Dermatitis—Vincristine—hematologic cancer	2.75e-05	0.000209	CcSEcCtD
Aminophylline—Haematuria—Doxorubicin—hematologic cancer	2.75e-05	0.000209	CcSEcCtD
Aminophylline—Headache—Vincristine—hematologic cancer	2.74e-05	0.000208	CcSEcCtD
Aminophylline—Hypotension—Dexamethasone—hematologic cancer	2.72e-05	0.000207	CcSEcCtD
Aminophylline—Hypotension—Betamethasone—hematologic cancer	2.72e-05	0.000207	CcSEcCtD
Aminophylline—Nausea—Carmustine—hematologic cancer	2.72e-05	0.000207	CcSEcCtD
Aminophylline—Vomiting—Mitoxantrone—hematologic cancer	2.71e-05	0.000206	CcSEcCtD
Aminophylline—Vomiting—Irinotecan—hematologic cancer	2.71e-05	0.000206	CcSEcCtD
Aminophylline—Nausea—Alitretinoin—hematologic cancer	2.69e-05	0.000205	CcSEcCtD
Aminophylline—Convulsion—Prednisone—hematologic cancer	2.69e-05	0.000205	CcSEcCtD
Aminophylline—Rash—Irinotecan—hematologic cancer	2.68e-05	0.000204	CcSEcCtD
Aminophylline—Rash—Mitoxantrone—hematologic cancer	2.68e-05	0.000204	CcSEcCtD
Aminophylline—Dermatitis—Mitoxantrone—hematologic cancer	2.68e-05	0.000204	CcSEcCtD
Aminophylline—Dermatitis—Irinotecan—hematologic cancer	2.68e-05	0.000204	CcSEcCtD
Aminophylline—Headache—Mitoxantrone—hematologic cancer	2.67e-05	0.000203	CcSEcCtD
Aminophylline—Headache—Irinotecan—hematologic cancer	2.67e-05	0.000203	CcSEcCtD
Aminophylline—Nausea—Ifosfamide—hematologic cancer	2.66e-05	0.000203	CcSEcCtD
Aminophylline—Diarrhoea—Cisplatin—hematologic cancer	2.64e-05	0.000201	CcSEcCtD
Aminophylline—Anxiety—Prednisone—hematologic cancer	2.64e-05	0.000201	CcSEcCtD
Aminophylline—Alopecia—Methotrexate—hematologic cancer	2.64e-05	0.000201	CcSEcCtD
Aminophylline—Vomiting—Gemcitabine—hematologic cancer	2.64e-05	0.000201	CcSEcCtD
Aminophylline—Insomnia—Betamethasone—hematologic cancer	2.64e-05	0.0002	CcSEcCtD
Aminophylline—Insomnia—Dexamethasone—hematologic cancer	2.64e-05	0.0002	CcSEcCtD
Aminophylline—Rash—Gemcitabine—hematologic cancer	2.61e-05	0.000199	CcSEcCtD
Aminophylline—Dermatitis—Gemcitabine—hematologic cancer	2.61e-05	0.000199	CcSEcCtD
Aminophylline—Hypersensitivity—Etoposide—hematologic cancer	2.61e-05	0.000198	CcSEcCtD
Aminophylline—Headache—Gemcitabine—hematologic cancer	2.6e-05	0.000198	CcSEcCtD
Aminophylline—Nausea—Vincristine—hematologic cancer	2.6e-05	0.000197	CcSEcCtD
Aminophylline—Flushing—Epirubicin—hematologic cancer	2.59e-05	0.000197	CcSEcCtD
Aminophylline—Hypersensitivity—Prednisolone—hematologic cancer	2.57e-05	0.000196	CcSEcCtD
Aminophylline—Dyspepsia—Dexamethasone—hematologic cancer	2.56e-05	0.000195	CcSEcCtD
Aminophylline—Dyspepsia—Betamethasone—hematologic cancer	2.56e-05	0.000195	CcSEcCtD
Aminophylline—Urticaria—Triamcinolone—hematologic cancer	2.55e-05	0.000194	CcSEcCtD
Aminophylline—Body temperature increased—Triamcinolone—hematologic cancer	2.54e-05	0.000193	CcSEcCtD
Aminophylline—Anaphylactic shock—Prednisone—hematologic cancer	2.54e-05	0.000193	CcSEcCtD
Aminophylline—Decreased appetite—Betamethasone—hematologic cancer	2.53e-05	0.000193	CcSEcCtD
Aminophylline—Decreased appetite—Dexamethasone—hematologic cancer	2.53e-05	0.000193	CcSEcCtD
Aminophylline—Nausea—Irinotecan—hematologic cancer	2.53e-05	0.000192	CcSEcCtD
Aminophylline—Nausea—Mitoxantrone—hematologic cancer	2.53e-05	0.000192	CcSEcCtD
Aminophylline—Infection—Prednisone—hematologic cancer	2.52e-05	0.000192	CcSEcCtD
Aminophylline—Pruritus—Etoposide—hematologic cancer	2.5e-05	0.000191	CcSEcCtD
Aminophylline—Shock—Prednisone—hematologic cancer	2.5e-05	0.00019	CcSEcCtD
Aminophylline—Arrhythmia—Epirubicin—hematologic cancer	2.5e-05	0.00019	CcSEcCtD
Aminophylline—Nervous system disorder—Prednisone—hematologic cancer	2.49e-05	0.000189	CcSEcCtD
Aminophylline—Tachycardia—Prednisone—hematologic cancer	2.48e-05	0.000188	CcSEcCtD
Aminophylline—Alopecia—Epirubicin—hematologic cancer	2.47e-05	0.000188	CcSEcCtD
Aminophylline—Nausea—Gemcitabine—hematologic cancer	2.46e-05	0.000187	CcSEcCtD
Aminophylline—Vomiting—Cisplatin—hematologic cancer	2.46e-05	0.000187	CcSEcCtD
Aminophylline—Rash—Cisplatin—hematologic cancer	2.44e-05	0.000185	CcSEcCtD
Aminophylline—Dermatitis—Cisplatin—hematologic cancer	2.43e-05	0.000185	CcSEcCtD
Aminophylline—Diarrhoea—Etoposide—hematologic cancer	2.42e-05	0.000184	CcSEcCtD
Aminophylline—Anorexia—Prednisone—hematologic cancer	2.42e-05	0.000184	CcSEcCtD
Aminophylline—Flushing—Doxorubicin—hematologic cancer	2.4e-05	0.000182	CcSEcCtD
Aminophylline—Tension—Epirubicin—hematologic cancer	2.39e-05	0.000182	CcSEcCtD
Aminophylline—Gastrointestinal pain—Betamethasone—hematologic cancer	2.38e-05	0.000181	CcSEcCtD
Aminophylline—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.38e-05	0.000181	CcSEcCtD
Aminophylline—Hypersensitivity—Triamcinolone—hematologic cancer	2.37e-05	0.00018	CcSEcCtD
Aminophylline—Nervousness—Epirubicin—hematologic cancer	2.36e-05	0.00018	CcSEcCtD
Aminophylline—Dizziness—Etoposide—hematologic cancer	2.34e-05	0.000178	CcSEcCtD
Aminophylline—Urticaria—Betamethasone—hematologic cancer	2.31e-05	0.000176	CcSEcCtD
Aminophylline—Urticaria—Dexamethasone—hematologic cancer	2.31e-05	0.000176	CcSEcCtD
Aminophylline—Dizziness—Prednisolone—hematologic cancer	2.31e-05	0.000176	CcSEcCtD
Aminophylline—Arrhythmia—Doxorubicin—hematologic cancer	2.31e-05	0.000176	CcSEcCtD
Aminophylline—Abdominal pain—Dexamethasone—hematologic cancer	2.3e-05	0.000175	CcSEcCtD
Aminophylline—Body temperature increased—Dexamethasone—hematologic cancer	2.3e-05	0.000175	CcSEcCtD
Aminophylline—Body temperature increased—Betamethasone—hematologic cancer	2.3e-05	0.000175	CcSEcCtD
Aminophylline—Abdominal pain—Betamethasone—hematologic cancer	2.3e-05	0.000175	CcSEcCtD
Aminophylline—Nausea—Cisplatin—hematologic cancer	2.3e-05	0.000175	CcSEcCtD
Aminophylline—Insomnia—Prednisone—hematologic cancer	2.3e-05	0.000175	CcSEcCtD
Aminophylline—Alopecia—Doxorubicin—hematologic cancer	2.28e-05	0.000174	CcSEcCtD
Aminophylline—Pruritus—Triamcinolone—hematologic cancer	2.27e-05	0.000173	CcSEcCtD
Aminophylline—Convulsion—Methotrexate—hematologic cancer	2.25e-05	0.000171	CcSEcCtD
Aminophylline—Vomiting—Etoposide—hematologic cancer	2.25e-05	0.000171	CcSEcCtD
Aminophylline—Agitation—Epirubicin—hematologic cancer	2.23e-05	0.00017	CcSEcCtD
Aminophylline—Dyspepsia—Prednisone—hematologic cancer	2.23e-05	0.00017	CcSEcCtD
Aminophylline—Rash—Etoposide—hematologic cancer	2.23e-05	0.00017	CcSEcCtD
Aminophylline—Dermatitis—Etoposide—hematologic cancer	2.23e-05	0.00017	CcSEcCtD
Aminophylline—Headache—Etoposide—hematologic cancer	2.22e-05	0.000169	CcSEcCtD
Aminophylline—Tension—Doxorubicin—hematologic cancer	2.21e-05	0.000168	CcSEcCtD
Aminophylline—Decreased appetite—Prednisone—hematologic cancer	2.21e-05	0.000168	CcSEcCtD
Aminophylline—Rash—Prednisolone—hematologic cancer	2.2e-05	0.000167	CcSEcCtD
Aminophylline—Dermatitis—Prednisolone—hematologic cancer	2.2e-05	0.000167	CcSEcCtD
Aminophylline—Headache—Prednisolone—hematologic cancer	2.19e-05	0.000166	CcSEcCtD
Aminophylline—Nervousness—Doxorubicin—hematologic cancer	2.19e-05	0.000166	CcSEcCtD
Aminophylline—Palpitations—Epirubicin—hematologic cancer	2.15e-05	0.000163	CcSEcCtD
Aminophylline—Dizziness—Triamcinolone—hematologic cancer	2.12e-05	0.000162	CcSEcCtD
Aminophylline—Anaphylactic shock—Methotrexate—hematologic cancer	2.12e-05	0.000161	CcSEcCtD
Aminophylline—Convulsion—Epirubicin—hematologic cancer	2.11e-05	0.00016	CcSEcCtD
Aminophylline—Infection—Methotrexate—hematologic cancer	2.11e-05	0.00016	CcSEcCtD
Aminophylline—Nausea—Etoposide—hematologic cancer	2.1e-05	0.00016	CcSEcCtD
Aminophylline—Nervous system disorder—Methotrexate—hematologic cancer	2.08e-05	0.000158	CcSEcCtD
Aminophylline—Gastrointestinal pain—Prednisone—hematologic cancer	2.07e-05	0.000158	CcSEcCtD
Aminophylline—Nausea—Prednisolone—hematologic cancer	2.07e-05	0.000158	CcSEcCtD
Aminophylline—Agitation—Doxorubicin—hematologic cancer	2.07e-05	0.000157	CcSEcCtD
Aminophylline—Anxiety—Epirubicin—hematologic cancer	2.06e-05	0.000157	CcSEcCtD
Aminophylline—Pruritus—Betamethasone—hematologic cancer	2.06e-05	0.000157	CcSEcCtD
Aminophylline—Pruritus—Dexamethasone—hematologic cancer	2.06e-05	0.000157	CcSEcCtD
Aminophylline—Vomiting—Triamcinolone—hematologic cancer	2.04e-05	0.000155	CcSEcCtD
Aminophylline—Rash—Triamcinolone—hematologic cancer	2.02e-05	0.000154	CcSEcCtD
Aminophylline—Dermatitis—Triamcinolone—hematologic cancer	2.02e-05	0.000154	CcSEcCtD
Aminophylline—Anorexia—Methotrexate—hematologic cancer	2.02e-05	0.000154	CcSEcCtD
Aminophylline—Urticaria—Prednisone—hematologic cancer	2.02e-05	0.000153	CcSEcCtD
Aminophylline—Headache—Triamcinolone—hematologic cancer	2.01e-05	0.000153	CcSEcCtD
Aminophylline—Abdominal pain—Prednisone—hematologic cancer	2.01e-05	0.000153	CcSEcCtD
Aminophylline—Body temperature increased—Prednisone—hematologic cancer	2.01e-05	0.000153	CcSEcCtD
Aminophylline—Diarrhoea—Dexamethasone—hematologic cancer	1.99e-05	0.000152	CcSEcCtD
Aminophylline—Diarrhoea—Betamethasone—hematologic cancer	1.99e-05	0.000152	CcSEcCtD
Aminophylline—Palpitations—Doxorubicin—hematologic cancer	1.99e-05	0.000151	CcSEcCtD
Aminophylline—Anaphylactic shock—Epirubicin—hematologic cancer	1.98e-05	0.000151	CcSEcCtD
Aminophylline—Hypotension—Methotrexate—hematologic cancer	1.98e-05	0.000151	CcSEcCtD
Aminophylline—Infection—Epirubicin—hematologic cancer	1.97e-05	0.00015	CcSEcCtD
Aminophylline—Shock—Epirubicin—hematologic cancer	1.95e-05	0.000149	CcSEcCtD
Aminophylline—Convulsion—Doxorubicin—hematologic cancer	1.95e-05	0.000148	CcSEcCtD
Aminophylline—Nervous system disorder—Epirubicin—hematologic cancer	1.95e-05	0.000148	CcSEcCtD
Aminophylline—Tachycardia—Epirubicin—hematologic cancer	1.94e-05	0.000147	CcSEcCtD
Aminophylline—Dizziness—Betamethasone—hematologic cancer	1.93e-05	0.000147	CcSEcCtD
Aminophylline—Dizziness—Dexamethasone—hematologic cancer	1.93e-05	0.000147	CcSEcCtD
Aminophylline—Insomnia—Methotrexate—hematologic cancer	1.92e-05	0.000146	CcSEcCtD
Aminophylline—Anxiety—Doxorubicin—hematologic cancer	1.91e-05	0.000145	CcSEcCtD
Aminophylline—Nausea—Triamcinolone—hematologic cancer	1.91e-05	0.000145	CcSEcCtD
Aminophylline—Anorexia—Epirubicin—hematologic cancer	1.89e-05	0.000144	CcSEcCtD
Aminophylline—Hypersensitivity—Prednisone—hematologic cancer	1.87e-05	0.000142	CcSEcCtD
Aminophylline—Dyspepsia—Methotrexate—hematologic cancer	1.87e-05	0.000142	CcSEcCtD
Aminophylline—Hypotension—Epirubicin—hematologic cancer	1.85e-05	0.000141	CcSEcCtD
Aminophylline—Vomiting—Dexamethasone—hematologic cancer	1.85e-05	0.000141	CcSEcCtD
Aminophylline—Vomiting—Betamethasone—hematologic cancer	1.85e-05	0.000141	CcSEcCtD
Aminophylline—Decreased appetite—Methotrexate—hematologic cancer	1.84e-05	0.00014	CcSEcCtD
Aminophylline—Rash—Dexamethasone—hematologic cancer	1.84e-05	0.00014	CcSEcCtD
Aminophylline—Rash—Betamethasone—hematologic cancer	1.84e-05	0.00014	CcSEcCtD
Aminophylline—Anaphylactic shock—Doxorubicin—hematologic cancer	1.84e-05	0.00014	CcSEcCtD
Aminophylline—Dermatitis—Dexamethasone—hematologic cancer	1.84e-05	0.00014	CcSEcCtD
Aminophylline—Dermatitis—Betamethasone—hematologic cancer	1.84e-05	0.00014	CcSEcCtD
Aminophylline—Headache—Dexamethasone—hematologic cancer	1.83e-05	0.000139	CcSEcCtD
Aminophylline—Headache—Betamethasone—hematologic cancer	1.83e-05	0.000139	CcSEcCtD
Aminophylline—Infection—Doxorubicin—hematologic cancer	1.82e-05	0.000139	CcSEcCtD
Aminophylline—Shock—Doxorubicin—hematologic cancer	1.81e-05	0.000137	CcSEcCtD
Aminophylline—Nervous system disorder—Doxorubicin—hematologic cancer	1.8e-05	0.000137	CcSEcCtD
Aminophylline—Pruritus—Prednisone—hematologic cancer	1.8e-05	0.000137	CcSEcCtD
Aminophylline—Insomnia—Epirubicin—hematologic cancer	1.8e-05	0.000137	CcSEcCtD
Aminophylline—Tachycardia—Doxorubicin—hematologic cancer	1.79e-05	0.000136	CcSEcCtD
Aminophylline—Anorexia—Doxorubicin—hematologic cancer	1.75e-05	0.000133	CcSEcCtD
Aminophylline—Dyspepsia—Epirubicin—hematologic cancer	1.75e-05	0.000133	CcSEcCtD
Aminophylline—Diarrhoea—Prednisone—hematologic cancer	1.74e-05	0.000132	CcSEcCtD
Aminophylline—Gastrointestinal pain—Methotrexate—hematologic cancer	1.73e-05	0.000132	CcSEcCtD
Aminophylline—Nausea—Betamethasone—hematologic cancer	1.73e-05	0.000132	CcSEcCtD
Aminophylline—Nausea—Dexamethasone—hematologic cancer	1.73e-05	0.000132	CcSEcCtD
Aminophylline—Decreased appetite—Epirubicin—hematologic cancer	1.73e-05	0.000131	CcSEcCtD
Aminophylline—Hypotension—Doxorubicin—hematologic cancer	1.72e-05	0.000131	CcSEcCtD
Aminophylline—Urticaria—Methotrexate—hematologic cancer	1.68e-05	0.000128	CcSEcCtD
Aminophylline—Dizziness—Prednisone—hematologic cancer	1.68e-05	0.000128	CcSEcCtD
Aminophylline—Abdominal pain—Methotrexate—hematologic cancer	1.68e-05	0.000128	CcSEcCtD
Aminophylline—Body temperature increased—Methotrexate—hematologic cancer	1.68e-05	0.000128	CcSEcCtD
Aminophylline—Insomnia—Doxorubicin—hematologic cancer	1.66e-05	0.000126	CcSEcCtD
Aminophylline—Gastrointestinal pain—Epirubicin—hematologic cancer	1.62e-05	0.000123	CcSEcCtD
Aminophylline—Dyspepsia—Doxorubicin—hematologic cancer	1.62e-05	0.000123	CcSEcCtD
Aminophylline—Vomiting—Prednisone—hematologic cancer	1.61e-05	0.000123	CcSEcCtD
Aminophylline—Rash—Prednisone—hematologic cancer	1.6e-05	0.000122	CcSEcCtD
Aminophylline—Dermatitis—Prednisone—hematologic cancer	1.6e-05	0.000122	CcSEcCtD
Aminophylline—Decreased appetite—Doxorubicin—hematologic cancer	1.6e-05	0.000121	CcSEcCtD
Aminophylline—Headache—Prednisone—hematologic cancer	1.59e-05	0.000121	CcSEcCtD
Aminophylline—Urticaria—Epirubicin—hematologic cancer	1.58e-05	0.00012	CcSEcCtD
Aminophylline—Body temperature increased—Epirubicin—hematologic cancer	1.57e-05	0.000119	CcSEcCtD
Aminophylline—Abdominal pain—Epirubicin—hematologic cancer	1.57e-05	0.000119	CcSEcCtD
Aminophylline—Hypersensitivity—Methotrexate—hematologic cancer	1.56e-05	0.000119	CcSEcCtD
Aminophylline—Nausea—Prednisone—hematologic cancer	1.51e-05	0.000115	CcSEcCtD
Aminophylline—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.5e-05	0.000114	CcSEcCtD
Aminophylline—Pruritus—Methotrexate—hematologic cancer	1.5e-05	0.000114	CcSEcCtD
Aminophylline—Hypersensitivity—Epirubicin—hematologic cancer	1.46e-05	0.000111	CcSEcCtD
Aminophylline—Urticaria—Doxorubicin—hematologic cancer	1.46e-05	0.000111	CcSEcCtD
Aminophylline—Abdominal pain—Doxorubicin—hematologic cancer	1.45e-05	0.00011	CcSEcCtD
Aminophylline—Body temperature increased—Doxorubicin—hematologic cancer	1.45e-05	0.00011	CcSEcCtD
Aminophylline—Diarrhoea—Methotrexate—hematologic cancer	1.45e-05	0.00011	CcSEcCtD
Aminophylline—Pruritus—Epirubicin—hematologic cancer	1.4e-05	0.000107	CcSEcCtD
Aminophylline—Dizziness—Methotrexate—hematologic cancer	1.4e-05	0.000107	CcSEcCtD
Aminophylline—Diarrhoea—Epirubicin—hematologic cancer	1.36e-05	0.000103	CcSEcCtD
Aminophylline—Hypersensitivity—Doxorubicin—hematologic cancer	1.35e-05	0.000103	CcSEcCtD
Aminophylline—Vomiting—Methotrexate—hematologic cancer	1.35e-05	0.000103	CcSEcCtD
Aminophylline—Rash—Methotrexate—hematologic cancer	1.34e-05	0.000102	CcSEcCtD
Aminophylline—Dermatitis—Methotrexate—hematologic cancer	1.34e-05	0.000102	CcSEcCtD
Aminophylline—Headache—Methotrexate—hematologic cancer	1.33e-05	0.000101	CcSEcCtD
Aminophylline—Dizziness—Epirubicin—hematologic cancer	1.31e-05	9.98e-05	CcSEcCtD
Aminophylline—Pruritus—Doxorubicin—hematologic cancer	1.3e-05	9.88e-05	CcSEcCtD
Aminophylline—Vomiting—Epirubicin—hematologic cancer	1.26e-05	9.6e-05	CcSEcCtD
Aminophylline—Nausea—Methotrexate—hematologic cancer	1.26e-05	9.58e-05	CcSEcCtD
Aminophylline—Diarrhoea—Doxorubicin—hematologic cancer	1.26e-05	9.56e-05	CcSEcCtD
Aminophylline—Rash—Epirubicin—hematologic cancer	1.25e-05	9.52e-05	CcSEcCtD
Aminophylline—Dermatitis—Epirubicin—hematologic cancer	1.25e-05	9.51e-05	CcSEcCtD
Aminophylline—Headache—Epirubicin—hematologic cancer	1.24e-05	9.46e-05	CcSEcCtD
Aminophylline—Dizziness—Doxorubicin—hematologic cancer	1.21e-05	9.24e-05	CcSEcCtD
Aminophylline—Nausea—Epirubicin—hematologic cancer	1.18e-05	8.97e-05	CcSEcCtD
Aminophylline—Vomiting—Doxorubicin—hematologic cancer	1.17e-05	8.88e-05	CcSEcCtD
Aminophylline—Rash—Doxorubicin—hematologic cancer	1.16e-05	8.81e-05	CcSEcCtD
Aminophylline—Dermatitis—Doxorubicin—hematologic cancer	1.16e-05	8.8e-05	CcSEcCtD
Aminophylline—Headache—Doxorubicin—hematologic cancer	1.15e-05	8.75e-05	CcSEcCtD
Aminophylline—Nausea—Doxorubicin—hematologic cancer	1.09e-05	8.3e-05	CcSEcCtD
Aminophylline—ADORA1—Signaling Pathways—IL2—hematologic cancer	3.18e-06	4.19e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—VEGFA—hematologic cancer	3.18e-06	4.18e-05	CbGpPWpGaD
Aminophylline—HDAC2—Gene Expression—MYC—hematologic cancer	3.18e-06	4.18e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—STAT3—hematologic cancer	3.17e-06	4.18e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—NRAS—hematologic cancer	3.17e-06	4.17e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—IL6—hematologic cancer	3.16e-06	4.17e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—FGF2—hematologic cancer	3.16e-06	4.16e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ABCC3—hematologic cancer	3.16e-06	4.16e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GSTO1—hematologic cancer	3.16e-06	4.16e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—TXN—hematologic cancer	3.16e-06	4.16e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—STAT3—hematologic cancer	3.15e-06	4.14e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—NRAS—hematologic cancer	3.14e-06	4.13e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—MAPK8—hematologic cancer	3.13e-06	4.12e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—AKT1—hematologic cancer	3.12e-06	4.1e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CDKN1A—hematologic cancer	3.12e-06	4.1e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—PIK3R1—hematologic cancer	3.12e-06	4.1e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—PTEN—hematologic cancer	3.11e-06	4.09e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CCND1—hematologic cancer	3.1e-06	4.08e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—JUN—hematologic cancer	3.09e-06	4.07e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—SPHK1—hematologic cancer	3.09e-06	4.07e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—MAP2K1—hematologic cancer	3.09e-06	4.07e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—FHL2—hematologic cancer	3.08e-06	4.06e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—PIK3CD—hematologic cancer	3.07e-06	4.04e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—EP300—hematologic cancer	3.05e-06	4.01e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—MAPK8—hematologic cancer	3.04e-06	4e-05	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR downstream signaling—PIK3CA—hematologic cancer	3.04e-06	4e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—AKT1—hematologic cancer	3.03e-06	3.99e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—MAPK3—hematologic cancer	3.03e-06	3.99e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—JAK2—hematologic cancer	3.03e-06	3.99e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—AGRN—hematologic cancer	3.02e-06	3.98e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—MAPK3—hematologic cancer	3.01e-06	3.96e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—KRAS—hematologic cancer	3e-06	3.95e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CDKN1A—hematologic cancer	3e-06	3.95e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—PTEN—hematologic cancer	2.99e-06	3.94e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—UGT1A1—hematologic cancer	2.97e-06	3.91e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—EP300—hematologic cancer	2.96e-06	3.9e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—SRC—hematologic cancer	2.96e-06	3.9e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—MDM2—hematologic cancer	2.96e-06	3.89e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—MYC—hematologic cancer	2.95e-06	3.88e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—TGFB1—hematologic cancer	2.94e-06	3.87e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—FGF2—hematologic cancer	2.94e-06	3.87e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—MAPK8—hematologic cancer	2.93e-06	3.85e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—MYC—hematologic cancer	2.92e-06	3.85e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—AKT1—hematologic cancer	2.92e-06	3.84e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—TGFB1—hematologic cancer	2.92e-06	3.84e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—PIK3R1—hematologic cancer	2.9e-06	3.81e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—SLC22A1—hematologic cancer	2.89e-06	3.8e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CRABP1—hematologic cancer	2.89e-06	3.8e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—VEGFA—hematologic cancer	2.89e-06	3.8e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—SRC—hematologic cancer	2.88e-06	3.8e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—MTOR—hematologic cancer	2.88e-06	3.79e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—PIK3CB—hematologic cancer	2.88e-06	3.79e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—IDH2—hematologic cancer	2.87e-06	3.77e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—HMMR—hematologic cancer	2.87e-06	3.77e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—STAT3—hematologic cancer	2.86e-06	3.76e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—EP300—hematologic cancer	2.85e-06	3.76e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—NRAS—hematologic cancer	2.85e-06	3.75e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—GSTP1—hematologic cancer	2.82e-06	3.72e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—JAK2—hematologic cancer	2.81e-06	3.71e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ALOX5—hematologic cancer	2.81e-06	3.71e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—VEGFA—hematologic cancer	2.81e-06	3.7e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—STAT3—hematologic cancer	2.78e-06	3.66e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—SRC—hematologic cancer	2.77e-06	3.65e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—NRAS—hematologic cancer	2.77e-06	3.65e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—PIK3CA—hematologic cancer	2.76e-06	3.63e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—MDM2—hematologic cancer	2.75e-06	3.62e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—MAPK3—hematologic cancer	2.73e-06	3.59e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—NUP98—hematologic cancer	2.73e-06	3.59e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—KRAS—hematologic cancer	2.72e-06	3.59e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—VEGFA—hematologic cancer	2.7e-06	3.56e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—KRAS—hematologic cancer	2.7e-06	3.56e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CDKN1B—hematologic cancer	2.7e-06	3.55e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ARNTL—hematologic cancer	2.69e-06	3.55e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—STAT3—hematologic cancer	2.68e-06	3.52e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—MTOR—hematologic cancer	2.67e-06	3.52e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—PIK3CB—hematologic cancer	2.67e-06	3.52e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—ABCB1—hematologic cancer	2.67e-06	3.52e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—NRAS—hematologic cancer	2.67e-06	3.51e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—MAPK3—hematologic cancer	2.66e-06	3.5e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—MYC—hematologic cancer	2.66e-06	3.5e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—TGFB1—hematologic cancer	2.65e-06	3.49e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ADCY7—hematologic cancer	2.65e-06	3.48e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—NCOA3—hematologic cancer	2.65e-06	3.48e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CASP3—hematologic cancer	2.64e-06	3.48e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—IL2—hematologic cancer	2.64e-06	3.48e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—NUP214—hematologic cancer	2.63e-06	3.46e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CA9—hematologic cancer	2.62e-06	3.45e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ACP5—hematologic cancer	2.62e-06	3.45e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.6e-06	3.42e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—GSTM1—hematologic cancer	2.59e-06	3.42e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—NCOR1—hematologic cancer	2.59e-06	3.42e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—NCOR2—hematologic cancer	2.59e-06	3.41e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—MYC—hematologic cancer	2.58e-06	3.4e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—TGFB1—hematologic cancer	2.58e-06	3.39e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CCND1—hematologic cancer	2.57e-06	3.39e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—MTR—hematologic cancer	2.57e-06	3.39e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ABCG2—hematologic cancer	2.57e-06	3.39e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—JUN—hematologic cancer	2.57e-06	3.38e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—MAPK3—hematologic cancer	2.56e-06	3.37e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—HRAS—hematologic cancer	2.55e-06	3.36e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ENO2—hematologic cancer	2.52e-06	3.32e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CDKN1B—hematologic cancer	2.51e-06	3.3e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—PIK3CA—hematologic cancer	2.5e-06	3.3e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CDKN1A—hematologic cancer	2.49e-06	3.28e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—MYC—hematologic cancer	2.49e-06	3.27e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—PTEN—hematologic cancer	2.48e-06	3.27e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—PIK3CA—hematologic cancer	2.48e-06	3.27e-05	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR downstream signaling—AKT1—hematologic cancer	2.48e-06	3.27e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—TGFB1—hematologic cancer	2.48e-06	3.27e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—IDH1—hematologic cancer	2.46e-06	3.25e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CASP3—hematologic cancer	2.46e-06	3.24e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—IL2—hematologic cancer	2.46e-06	3.23e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—KRAS—hematologic cancer	2.45e-06	3.23e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GSTT1—hematologic cancer	2.45e-06	3.22e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—IL6—hematologic cancer	2.44e-06	3.22e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GSTO1—hematologic cancer	2.44e-06	3.21e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ABCC3—hematologic cancer	2.44e-06	3.21e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—TXN—hematologic cancer	2.44e-06	3.21e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—MAPK8—hematologic cancer	2.43e-06	3.2e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.41e-06	3.17e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—TP53—hematologic cancer	2.4e-06	3.16e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CCND1—hematologic cancer	2.39e-06	3.15e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—SDC1—hematologic cancer	2.39e-06	3.15e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—JUN—hematologic cancer	2.39e-06	3.14e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—KRAS—hematologic cancer	2.39e-06	3.14e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—SPHK1—hematologic cancer	2.38e-06	3.14e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—EP300—hematologic cancer	2.37e-06	3.12e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—HRAS—hematologic cancer	2.32e-06	3.05e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CDKN1A—hematologic cancer	2.32e-06	3.05e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—PTEN—hematologic cancer	2.31e-06	3.04e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—SRC—hematologic cancer	2.3e-06	3.03e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—KRAS—hematologic cancer	2.3e-06	3.02e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—HRAS—hematologic cancer	2.3e-06	3.02e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—MTHFR—hematologic cancer	2.29e-06	3.02e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—UGT1A1—hematologic cancer	2.29e-06	3.02e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.29e-06	3.01e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—MAPK8—hematologic cancer	2.26e-06	2.98e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.26e-06	2.97e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—PIK3CA—hematologic cancer	2.25e-06	2.97e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—AKT1—hematologic cancer	2.25e-06	2.97e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—VEGFA—hematologic cancer	2.24e-06	2.96e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—SLC22A1—hematologic cancer	2.23e-06	2.93e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CRABP1—hematologic cancer	2.23e-06	2.93e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—STAT3—hematologic cancer	2.22e-06	2.93e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—NRAS—hematologic cancer	2.22e-06	2.92e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—IL6—hematologic cancer	2.22e-06	2.92e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—EP300—hematologic cancer	2.2e-06	2.9e-05	CbGpPWpGaD
Aminophylline—HDAC2—Gene Expression—AKT1—hematologic cancer	2.2e-06	2.9e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—IL6—hematologic cancer	2.2e-06	2.89e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—PIK3CA—hematologic cancer	2.19e-06	2.89e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—TP53—hematologic cancer	2.18e-06	2.87e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.17e-06	2.86e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.16e-06	2.84e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—SRC—hematologic cancer	2.14e-06	2.82e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—MAPK3—hematologic cancer	2.12e-06	2.8e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—TP53—hematologic cancer	2.12e-06	2.79e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—PIK3CA—hematologic cancer	2.11e-06	2.78e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—NUP98—hematologic cancer	2.1e-06	2.77e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—VEGFA—hematologic cancer	2.09e-06	2.75e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—HRAS—hematologic cancer	2.09e-06	2.75e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—STAT3—hematologic cancer	2.07e-06	2.72e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—MYC—hematologic cancer	2.07e-06	2.72e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—NRAS—hematologic cancer	2.06e-06	2.71e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—TGFB1—hematologic cancer	2.06e-06	2.71e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—AKT1—hematologic cancer	2.04e-06	2.69e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.04e-06	2.69e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.04e-06	2.69e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—TP53—hematologic cancer	2.04e-06	2.69e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CD44—hematologic cancer	2.03e-06	2.68e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—NQO1—hematologic cancer	2.03e-06	2.68e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—HRAS—hematologic cancer	2.03e-06	2.67e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—AKT1—hematologic cancer	2.03e-06	2.67e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—NUP214—hematologic cancer	2.03e-06	2.67e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—IL6—hematologic cancer	2e-06	2.63e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.99e-06	2.62e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ABCG2—hematologic cancer	1.99e-06	2.62e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—MTR—hematologic cancer	1.99e-06	2.62e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—MAPK3—hematologic cancer	1.97e-06	2.6e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—HRAS—hematologic cancer	1.95e-06	2.57e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ENO2—hematologic cancer	1.95e-06	2.57e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—IL6—hematologic cancer	1.94e-06	2.56e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PIK3CG—hematologic cancer	1.93e-06	2.54e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CYCS—hematologic cancer	1.93e-06	2.54e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—MYC—hematologic cancer	1.92e-06	2.53e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—TGFB1—hematologic cancer	1.92e-06	2.52e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	1.91e-06	2.52e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—KRAS—hematologic cancer	1.91e-06	2.51e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GSTT1—hematologic cancer	1.89e-06	2.49e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—IL6—hematologic cancer	1.87e-06	2.46e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—SDC1—hematologic cancer	1.85e-06	2.43e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—AKT1—hematologic cancer	1.84e-06	2.42e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—AKT1—hematologic cancer	1.79e-06	2.36e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—CREBBP—hematologic cancer	1.79e-06	2.35e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—KRAS—hematologic cancer	1.77e-06	2.34e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—PIK3CA—hematologic cancer	1.75e-06	2.31e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—AKT1—hematologic cancer	1.72e-06	2.27e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.72e-06	2.27e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GSTP1—hematologic cancer	1.7e-06	2.23e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—TP53—hematologic cancer	1.7e-06	2.23e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PIK3CD—hematologic cancer	1.69e-06	2.23e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—ALB—hematologic cancer	1.67e-06	2.2e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.64e-06	2.16e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—PIK3CA—hematologic cancer	1.63e-06	2.15e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—HRAS—hematologic cancer	1.62e-06	2.14e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ABCB1—hematologic cancer	1.61e-06	2.12e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PIK3R1—hematologic cancer	1.6e-06	2.11e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—TP53—hematologic cancer	1.58e-06	2.08e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—NQO1—hematologic cancer	1.57e-06	2.07e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CD44—hematologic cancer	1.57e-06	2.07e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GSTM1—hematologic cancer	1.56e-06	2.05e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—NCOR1—hematologic cancer	1.56e-06	2.05e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—IL6—hematologic cancer	1.55e-06	2.04e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—HRAS—hematologic cancer	1.51e-06	1.99e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CYCS—hematologic cancer	1.49e-06	1.96e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.48e-06	1.94e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PIK3CB—hematologic cancer	1.48e-06	1.94e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—IL6—hematologic cancer	1.44e-06	1.9e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—AKT1—hematologic cancer	1.43e-06	1.89e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.38e-06	1.81e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—AKT1—hematologic cancer	1.33e-06	1.75e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.31e-06	1.72e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PTEN—hematologic cancer	1.28e-06	1.68e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.24e-06	1.63e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—EP300—hematologic cancer	1.22e-06	1.6e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.21e-06	1.6e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.2e-06	1.58e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.2e-06	1.58e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.16e-06	1.52e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.07e-06	1.41e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.06e-06	1.4e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.02e-06	1.34e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ALB—hematologic cancer	1e-06	1.32e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PIK3R1—hematologic cancer	9.61e-07	1.27e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PIK3CA—hematologic cancer	9e-07	1.18e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PIK3CG—hematologic cancer	8.94e-07	1.18e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PIK3CB—hematologic cancer	8.87e-07	1.17e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CREBBP—hematologic cancer	8.29e-07	1.09e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PIK3CD—hematologic cancer	7.86e-07	1.03e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ALB—hematologic cancer	7.76e-07	1.02e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PTEN—hematologic cancer	7.67e-07	1.01e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PIK3R1—hematologic cancer	7.42e-07	9.77e-06	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—AKT1—hematologic cancer	7.35e-07	9.68e-06	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—EP300—hematologic cancer	7.31e-07	9.63e-06	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PIK3CB—hematologic cancer	6.85e-07	9.02e-06	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PTEN—hematologic cancer	5.92e-07	7.79e-06	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—EP300—hematologic cancer	5.64e-07	7.43e-06	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PIK3CA—hematologic cancer	5.41e-07	7.12e-06	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—AKT1—hematologic cancer	4.42e-07	5.82e-06	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PIK3CA—hematologic cancer	4.17e-07	5.5e-06	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—AKT1—hematologic cancer	3.41e-07	4.49e-06	CbGpPWpGaD
